Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Epidermolysis Bullosa

• An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa
• CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa
• Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)
• Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis Bullosa
• Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
• Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)
• Extension Study to PTR-01-002
• Vitamin D Status and Bone Metabolism Status in Children With Congenital Epidermolysis Bullosa
• Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells Genetically Modified for Epidermis Restoration in Patients With Junctional Epidermolysis Bullosa
• Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex
• INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa
• Topical Gentamicin Nonsense Suppression Therapy of EB
• The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial
• A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa
• Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB
• A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa
• Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC
• MSC EVs in Dystrophic Epidermolysis Bullosa
• Optimizing IV Gentamicin in JEB
• Pregabalin Treatment for RDEB Pain and Itch
• A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa
• Rigosertib for RDEB-SCC
• A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
• Evaluation of the Efficacy of ROPIVACAINE in Children and Young Adults With Hereditary Epidermolysis Bullosa
• A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With Confirmed DDEB or RDEB Diagnosis With One or More Path
• Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa
• Gentamicin for Junctional Epidermolysis Bullosa
• To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)
• A Double-blind, Intra-individual Comparison, POC Trial of AC-203 in EB Patients
• Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex
• Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
• Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
• Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS)
• Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa
• Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study
• Gentamicin for RDEB
• Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB.
• Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study
• A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
• Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa
• Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients
• Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa
• Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients
• Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
• MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs
• Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa
• Diacerin for the Treatment of Epidermolysis Bullosa Simplex
• ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa
• Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa
• Open-Label Extension Study to Evaluate the Safety of SD-101 Cream in Participants With Epidermolysis Bullosa
• Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa
• Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
• Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin
• Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10)
• Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs
• Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa
• Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)
• Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
• Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
• Study of Alwextin® Cream in Treating Epidermolysis Bullosa
• Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
• The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa
• Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa
• A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
• Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa
• Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa
• Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita